Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chuan Qi
OpenAlex ID:
A5010130917
First-line osemitamab (TST001) plus nivolumab and CAPOX for advanced G/GEJ cancer (TranStar102): Updated results of cohort G from a phase I/IIa study.
2025
·
Jifang Gong
, Dan Liu
, et al.
·
Journal of Clinical Oncology
·
14
A phase I study of TST001, a high affinity humanized anti-CLDN18.2 monoclonal antibody, in combination with capecitabine and oxaliplatin (CAPOX) as a first-line treatment of advanced G/GEJ cancer.
2022
·
Jifang Gong
, Ning Li
, et al.
·
Journal of Clinical Oncology
·
9
Abstract CT132: A Phase I/IIa clinical trial (TranStar101) to evaluate the safety, tolerability and pharmacokinetics of OSEMITAMAB administered as monotherapy or in combination with nivolumab or standard of care in patients with locally advanced or metastatic solid tumors
2024
·
Yelena Janjigian
, Anthony Tolcher
, et al.
·
Cancer Research
·
8
Abstract 5977: A first-in-human, open-label, multi-center phase 1 study of TST003, a GREM 1 inhibitor, in subjects with locally advanced or metastatic solid tumors
2024
·
Ismael Rodriguez Rivera
, Lin Shen
, et al.
·
Cancer Research
·
5
TST001 (a high affinity humanized anti-claudin18.2 monoclonal antibody) in combination with nivolumab plus capecitabine and oxaliplatin as first-line or with nivolumab as late-line treatment in locally advanced and metastatic gastric/gastroesophageal junction (G/GEJ) cancer: Design of cohorts from a phase I/IIa study (TST001-1002).
2023
·
Weijian Guo
, Caroline Germa
, et al.
·
Journal of Clinical Oncology
·
3
Abstract 2645: Characterization of osemitamab in pancreatic cancer models and patients.
2026
·
Fei Teng
, Huanhuan Guo
, et al.
·
Cancer Research
·
1
Phase I study of MSB2311, a novel pH-dependent anti-PD-L1 monoclonal antibody, treating patients with advanced solid tumors and lymphoma
2023
·
Qi Zhang
, Jian Zhang
, et al.
·
Cancer Immunology Immunotherapy
·
1
PDF
A phase I study to evaluate the safety, tolerability, and pharmacokinetics of MSB0254 in Chinese patients with solid tumors.
2022
·
Tianshu Liu
, Yulong Zheng
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
8
Citation count:
41
H-index:
4
I10-index:
1
Year
Topic
Type